Loading

Journal of Neurological Disorders and Stroke

Densitometric Evaluation and Fragility Fractures after Spinal Cord Injury

Review Article | Open Access | Volume 12 | Issue 1

  • 1. Department of Radiology and Diagnostic Imaging, Rede SARAH de Hospitais de Reabilitação, Brazil
+ Show More - Show Less
Corresponding Authors
Antonio Cunha Jr, Department of Radiology and Diagnostic Imaging, Rede SARAH de Hospitais de Reabilitação, Av. Amazonas, 5953. Gameleira, 30510-000, Belo Horizonte, MG, Brazil
ABSTRACT

Background: Spinal cord injury (SCI) can lead to serious complications, including bone loss and fragility fractures, making it important for radiologists to understand the frequencies and risk factors associated with these complications.

Purpose: To describe the frequencies of bone mineral density (BMD) changes and fragility fractures after SCI in participants who underwent dual-energy X-ray absorptiometry (DXA).

Materials and Methods: A retrospective chart review in a single rehabilitation center between December 2019 and August 2021 of participants with SCI who underwent DXA. Participants were divided into groups based on traumatic SCI, nontraumatic SCI, and simultaneous brain and SCIs. Within each group, participants were classified based on the presence or absence of fragility fractures and the results of BMD measurements. DXA measurements were assessed following the norms of the International Society of Clinical Densitometry. The knee BMD measurements followed the Toronto protocol. Blinded and independent evaluations were performed, and statistical analysis was performed using Fisher’s exact test.

Results: Of a total of 358 participants with SCI (mean age 41 years +/- 15.4 [standard deviation]; 221 men), 263/358 (73.5%) had traumatic SCI, 68/358 (19.0%) had nontraumatic SCI, and 27/358 (7.5%) had simultaneous brain and SCIs. Osteoporosis was identified in 81/358 (22.6%) participants, with the highest rate seen in those with nontraumatic SCI (28/68, 41.2%). Fragility fractures were observed in 46/358 (12.9%), with the highest rate seen in those with nontraumatic SCI (14/68, 20.6%). There was a statistically significant association between fragility fractures and osteoporosis in participants with SCI (p=0.005, OR=3.9, 95% CI: 1.4-12.7).

Conclusion: Almost one in five participants with SCI had osteoporosis, and more than one in 10 had fragility fractures. Nontraumatic SCI was associated with higher rates of osteoporosis and fragility fractures. Our study highlights the importance of monitoring bone health in SCI patients, particularly those with nontraumatic SCI.

Keywords

• Spinal cord injury; Bone mineral density; Dual energy X–ray absorptiometry; Osteoporosis; Fragility fractures

CITATION

Cunha A, Jr (2025) Densitometric Evaluation and Fragility Fractures after Spinal Cord Injury. J Neurol Disord Stroke 12(1): 1231.

ABBREVIATIONS

SCI: Spinal Cord Injury; BMD: Bone Mineral Density; DXA: Dual-Energy X–Ray Absorptiometry; ROI: Region of Interest; RMS: Root-Mean-Square; CV: Coefficient of Variation; SD: Standard Deviation; IQR: Interquartile Range; OR: Odds Ratio; CI: Confidence Interval

INTRODUCTION

Spinal cord injury (SCI) is a devastating condition that affects the skeletal system, motor and sensory functions [1- 9]. SCI patients are at high risk of developing bone loss and fragility fractures, which can have consequences for their quantity and quality of life [3-17]. Bone loss mainly occurs in the paralyzed extremities, primarily the knees [1,4,6,8,11,12,15,16,18-24]. The locations of fractures in SCI patients include the distal femur, proximal femur, and tibia and/or distal fibula [5-8,11,14-16,21,23,25-28].

Measurement of bone mineral density (BMD) is essential for diagnosing and monitoring bone loss following a permanent motor deficit [6,8-10,16-18,20,22,28,29]. Dual energy X-ray absorptiometry (DXA) provides the necessary precision and reliability for assessing BMD and monitoring bone loss. DXA is the most clinically useful method due to its low radiation exposure [18,30]. Precision studies are performed to ensure a properly quantitative bone density measurement [6,20,31-33]. The assessment of BMD in SCI patients is challenging due to various factors such as spinal arthrodesis, scoliosis, venous thromboembolism prophylaxis devices (vena cava filters), and heterotopic ossification in the hip [5,19,34] as shown in Figure 1.

Figure 1 Difficulties in measuring bone mineral density by dual energy X-ray absorptiometry in spinal cord injury: Spinal arthrodesis, vena cava filter, and heterotopic ossification in the hips.

Figure 1: Difficulties in measuring bone mineral density by dual energy X-ray absorptiometry in spinal cord injury: Spinal arthrodesis, vena cava filter, and heterotopic ossification in the hips.

Knee BMD measurements have been shown to be highly reliable [8,9,10,16,17,22,28], and DXA allows reduced exposure to ionizing radiation [8,9]. SCI patients require multiple imaging methods due to several complications. As many of these SCI patients are young and require frequent imaging tests to manage their condition, reducing the X-ray dose is critical, particularly given the increased survival of SCI patients due to improved health care [9,12,13].

Considerations should be given to conducting DXA before prescribing weight-bearing upright activities [6,9,22,25,28,34]. The fracture threshold at the knee was originally reported and later confirmed to be approximately a BMD of 0.780 g/cm2, while the breakpoint was found to be approximately 0.490 g/cm2. [11,17,28] According to the International Society of Clinical Densitometry’s 2019 guidelines [6], a distal femur BMD value of 0.561 g/cm2 has been suggested as an indicator for treatment. SCI individuals with fragility fractures had lower bone density at the femoral neck (mean BMD = 0.504 g/cm2) than those without fractures (0.786 g/cm2). Additionally, there was a reduction in knee BMD in SCI patients with a history of fractures compared to those without fractures [6,17].

Considering that context, this study aimed to describe the frequency of BMD changes and fragility fractures after SCI in participants who underwent DXA. By shedding light on these issues, our work contributes to a better understanding of the bone health status of SCI patients and may help guide clinical decision-making for their care.

MATERIAL AND METHODS

We conducted a retrospective chart review at a single rehabilitation center in … unit of the … Network of Rehabilitation Hospitals between December 2019 and August 2021. The project protocol was approved by the institution’s ethics committee (CAAE: 53530021.8.0000.0022).

Participants

The study included consecutive patients over 15 years old with DXA data and a clinically and radiologically confirmed diagnosis of SCI. In this manuscript we report the chance of fragility fractures in patients with SCI and osteoporosis compared with those with SCI and normal bone mineral density. The flow chart of the study is described in Figure 2.

Figure 2 Flow chart of the spinal cord injury study and dual-energy X-ray absorptiometry (DXA)

Figure 2: Flow chart of the spinal cord injury study and dual-energy X-ray absorptiometry (DXA)

The neurological level of injury was classified according to the 2019 version of the International Standards for Neurological Classification of SCIs as cervical, thoracic, lumbar, or sacral. We used the American Spinal Injury Association Impairment Scale for the classification of the level of injury as complete or incomplete. The American Spinal Injury Association Impairment Scale is a classification system used to describe the degree of impairment and function after a SCI [35].

Participants were divided based on the type of SCI, whether it was related to trauma or not, and the presence of simultaneous brain injury. In the latter group, cerebral involvement was due to demyelinating diseases or an associated traumatic brain injury at the time of the SCI event. Within each group, participants were further classified based on the presence or absence of fragility fractures and the results of BMD measurements, which were categorized as normal, below the expected range for age, or indicative of osteoporosis.

The study population consisted of 358 patients who underwent DXA. To calculate the required sample size, we determined that the proportion of patients with fragility fractures was 12.9%, the permissible error was 0.05, and the confidence level was 95%, resulting in a sample size of 117 participants.

Assessment and Image Acquisition and Analysis

We obtained data from electronic records that included information about all participants. A multidisciplinary team conducted independent clinical and BMD evaluations for each patient. We collected data on age, height, weight, and sex, as well as menopausal status, hypertension, diabetes, dyslipidemia, alcohol use, smoking, corticosteroid therapy, and fragility fractures, which were defined using the International Statistical Classification of Diseases, tenth revision codes. Traumatic fractures, resulting from falls from a height greater than standing, sports injuries, and motor vehicle/motorcycle accidents in 36 participants were not considered for analysis.

We performed a systematic and retrospective evaluation of DXA using Lunar Prodigy Advance equipment (GE-Lunar) with ENCORE software, version 18 [SP 1]. We assessed the spine, hip (total femur and femoral neck on both sides of the body), and forearm according to the norms of the International Society of Clinical Densitometry [29]. We also evaluated the right and left knee BMD measurements following the Toronto protocol,6 which assessed three regions of interest (ROIs) of equal area (4×10 cm): two measurements at the distal femur (one at the metaphysis and the other at the epiphysis) and one measurement at the proximal tibia (epiphysis), as shown in Figure 3.

Figure 3 Knee dual-energy X-ray absorptiometry (DXA): regions of interest (ROIs) of equal area (4×10 cm) - measurements at the distal femur (metaphysis and epiphysis) and at the proximal tibia (epiphysis).

Figure 3: Knee dual-energy X-ray absorptiometry (DXA): regions of interest (ROIs) of equal area (4×10 cm) - measurements at the distal femur (metaphysis and epiphysis) and at the proximal tibia (epiphysis).

We calculated root-mean-square (RMS), the RMS coefficient of variation (CV) and RMS standard deviation (SD) [31] at the distal metaphysis femoral, distal epiphysis femoral, and proximal epiphysis tibial, as described in our another study [17].

Statistical analysis

Data were analyzed using the open-source R statistical programming software (R Core Team, 2020). Nominal variables were expressed as numbers and percentages, while continuous variables were presented as medians, SD and interquartile ranges (IQRs) due to nonnormal distribution based on the Shapiro?Wilk test. To assess the association between fragility fractures and alterations in BMD in patients with SCI, we performed a 2 x 2 table analysis. Fisher’s exact test was used to calculate odds ratios (ORs) and 95% confidence intervals (CIs) for the categorical variables of fragility fracture and BMD status (normal BMD vs. below the expected range for age and normal BMD vs. osteoporosis). A p value of less than 0.05 was considered statistically significant.

RESULTS

Participant demographics

A total of 358 participants with available DXA data and SCI were included in the study, out of which 221/358 (61.7%) were male. The age range of the participants was from 15 to 85 years. The age distribution was asymmetric across decades. There was a larger number of participants in the fourth decade. The mean age was 41 years, with a SD of 15.4 years. The median age was 41 years (IQR 30–56 years). The median time of permanent motor deficits was 5 years (IQR 2–14 years) since SCI. The demographics of the participants are summarized in Table 1.

Table 1. Demographics of the study participants

Demographics

Participants (median and IQR or %)

Age (years) – Median (IQR)

41 (30–56)

Sex (female)

137/358 (38.3%)

Menopause

72/137 (52.6%)

Menopause time (years) – Median (IQR)

12 (7–17)

Height (cm) – Median (IQR)

168 (160–175)

Weight (kg) – Median (IQR)

69.3 (58.9–78.9)

SCI length (years) – Median (IQR)

5 (2–14)

Hypertension

76/358 (21.2%)

Diabetes mellitus

54/358 (15.1%)

Dyslipidemia

109/358 (30.4%)

Alcoholism

114/358 (31.8%)

Smokers

75/358 (20.9%)

Corticosteroid therapy

35/358 (9.8%)

Fragility fractures

46/358 (12.9%)

Traumatic fracture

36/358 (10.1%)

Note. – IQR: interquartile range.

SCI was traumatic in 263/358 (73.5%) participants, nontraumatic in 68/358 (19.0%) participants and associated with a brain lesion in 27/358 (7.5%) participants. In terms of American Spinal Injury Association Impairment Scale, SCI classes were A in 183/358 (51.1%) participants, B in 39/358 (10.9%) participants, C in 58/358 (16.2%) participants and D in 19/358 (16.5%) participants. American Spinal Injury Association Impairment Scale classification was not performed in 59/358 (16.5%) participants. Of the SCI neurological levels, the thoracic SCI level was the most frequent with 297/358 (57.8%) participants. This was followed by cervical with 6/358 (19.0%) participants, lumbar with 35/358 participants (9.8%), and 1/358 (0.3%) sacral participant. The level of injury could not be measured in 47/358 (13.1%). The American Spinal Injury Association Impairment Scale classes and SCI neurological levels are available in Figures 4 and 5.

Figure 4Frequencies of the different ASIA (American Spinal Injury Association) impairment scale (AIS) classes of the study participants

Figure 4: Frequencies of the different ASIA (American Spinal Injury Association) impairment scale (AIS) classes of the study participants

Figure 5 Frequencies of different neurological level injuries of the study participants.

Figure 5: Frequencies of different neurological level injuries of the study participants.

We compared the demographic data of the three groups with SCI and found some differences among the groups. In the traumatic SCI group, the median age of participants was 39 years (IQR: 29-52), and there were fewer menopausal women (31/263, 11.8%) and a higher median height of 170 cm (IQR: 164-175). A greater number of participants reported alcohol use (93/263, 35.5%) and were found to have traumatic fractures (33/263, 12.5%) in the traumatic SCI group. In contrast, participants with nontraumatic SCI were older, with a median age of 54 years (IQR: 37 64) and had a higher proportion of women (48/68, 70.6%) and menopausal women (31/68, 45.6%) with an average menopause duration of 11 years (IQR: 9-19). Comorbidities such as diabetes mellitus (20/68, 29.4%),dyslipidemia (29/68, 42.6%), and smoking (18/68, 26.5%) were more prevalent in this group. In the simultaneous SCI and brain injury group, 13/27 (48.1%) participants received corticosteroid therapy. The duration of disability and permanent motor impairment were similar across all three groups. The details comparing the demographic data among groups with SCI are presented in Table 2.

Table 2: Demographics of the spinal cord injury (SCI) groups

Demographics

SCI Trauma

SCI No

Trauma

SCI + Brain Injury

n = 358

263/358

(73.5%)

68/358

(19.0%)

27/358 (7.5%)

Age (years) – Median (IQR)

39 (29-52)

54 (37-64)

40 (33-57)

Sex (female)

72/263 (27.4%)

48/68

(70.6%)

17/27 (63.0 %)

Menopause

31/263

(11.8%)

31/68

(45.6%)

10/27 (37.0%)

Menopause time (years) – Median (IQR)

12 (8-16)

11 (9-19)

9 (4-18)

Height (cm) – Median (IQR)

170 (164-

175)

162 (156-168)

161 (155-169)

Weight (kg) – Median (IQR)

70 (60-79)

67 (57-76)

71 (56-82)

SCI time (years) – Median (IQR)

5 (2-12)

7 (2-18)

6 (2-21)

Hypertension

38/263

(14.4%)

30/68 (44.1%)

8 /27

(29.6%)

Diabetes mellitus

27/263 (10.2%)

20/68 (29.4%)

7/27 (25.9%)

Dyslipidemia

70/263 (26.6%)

29/68 (42.6%)

10/27 (37.0%)

Alcoholism

93/263 (35.4%)

17/68 (25.0%)

4/27 (14.8%)

Smokers

56/263

(21.2%)

17/68 (25.0%)

2/27 (7.4%)

Corticosteroid therapy

4/263

(1.5%)

18/68

(26.5%)

13/27 (48.2%)

Traumatic fractures

33/263

(12.5%)

0 /68

(0.0%)

3/27 (11.1%)

Note. – SCI: spinal cord injury; IQR: interquartile range.

Fragility fractures and BMD

Fragility fractures occurred in 46/358 (12.9%) participants. Fragility fracture was more frequent in participants with nontraumatic SCI occurring in 14/68 (20.6%). In the group with simultaneous SCI and brain injury, the frequency was 3/27 (11.1%), and there were fragility fractures in 29/263 (11.0%) of the traumatic SCI participant, as shown in Table 3.

Table 3: Proximal femur and knee dual–energy X–ray absorptiometry (DXA) diagnoses among the spinal cord injury (SCI) groups

DXA

SCI

SCI

Trauma

SCI No

Trauma

SCI + Brain Injury

Fragility fractures

46/358

(12.9%)

29/263 (11.0%)

14/68

(20.6%)

3/27 (11.1%)

Postmenopausal,

males aged > 50

130/358 (36.3%)

78/263 (29.7%)

40/68 (58.8%)

12/27 (44.4%)

Prior to menopause, males aged < 50

228/358

(63.7%)

185/263

(70.3%)

28/68

(41.2%)

15/27 (55.6%)

Osteoporosis*

T score < -2.5

81/358

(22.6%)

45/263

(17.1%)

28/68

(41.2%)

8/27 (29.6%)

Fragility fractures +

Osteoporosis

19/358 (5.3%)

10/263 (3.8%)

8/68

(11.8%)

1/27 (3.7%)

Low bone density

194/358 (54.2%)

168/263

(63.9%)

35/68

(51.5%)

11/27 (40.7%)

-2.5 < T score < -1.0

31/358

(8.7%)

24/263

(9.1%)

24/68

(35.3%)

3/27 (11,1%)

Z score < -2.0

163/358

(45.5%)

144/263

(54.8%)

11/68

(16.2%)

8/27 (29.6%)

Fragility fractures +

Low bone density

21/358

(5.9%)

14/263

(5.3%)

5/68

(7.4%)

2/27 (7.4%)

Normal BMD*

83/358

(23.1%)

50/263 (19.0%)

25/68

(36.8%)

8/27 (29.6%)

T score > -1.0

11/358

(3.1%)

9/263 (3.4%)

1/68

(1.5%)

1/27 (3.7%)

Z score > -2.0

72/358 (20.1%)

41/263

(15.6%)

24/68

(35.3%)

7/27 (25.9%)

Fragility fractures + Normal

BMD

6/358

(1.7%)

5/263

(1.9%)

1/68

(1.5%)

0/27 (0.0%)

Note. – DXA: dual-energy X-ray absorptiometry; SCI: spinal cord injury. BMD: bone mineral density; *according to International Society for Clinical Densitometry, 2019.

Osteoporosis was present in 81/358 (22.6%) of the study sample. Osteoporosis was more common in the nontraumatic SCI group, with 28/68 (41.2%) having this condition and fragility fractures and in 8/68 (11.8%) participants who had both osteoporosis and fragility fractures. In the traumatic SCI group, a higher proportion of participants had low bone density with 168/263 (63.9%) affected. However, fractures in participants with low bone density (osteopenia or below the expected range for age) were more frequent in the nontraumatic SCI group (5/68, 7.4%) and in the simultaneous SCI and brain injury group with (2/27, 7.4%). These findings are summarized in Table 3.

There was a statistically significant association (p=0.005) between the presence of fragility fractures and osteoporosis in participants with SCI (OR = 3.9, CI = 1.4 to 12.7), indicating that the chance of fragility fractures is nearly four times higher in patients with SCI and osteoporosis than in those with SCI and normal BMD by DXA.

BMD

The median BMD in patients with SCI is lower in the hips and knees, especially in the proximal tibias, while the median BMD is higher when evaluating the spine and forearm, as shown in Figure 6.

Figure 6 Bone mineral density (BMD) of the regions of interest (ROI) in the study participants with spinal cord injury (SCI).

Figure 6: Bone mineral density (BMD) of the regions of interest (ROI) in the study participants with spinal cord injury (SCI).

The median BMD in patients with nontraumatic SCI was lower in almost all evaluated sites, especially in the proximal tibia, as shown in Table 4.

Table 4: Bone mineral density (BMD) medians and interquartile ranges (IQRs) of the different spinal cord injury (SCI) groups

 

ROI/BMD (g/cm2)

SCI Trauma Median (IQR)

SCI No Trauma Median (IQR)

SCI + Brain Injury Median (IQR)

 

Right total hip*

0.749

(0.624–0.872)

0.732

(0.641–0.851)

0.787

(0.662–0.925)

 

Right femoral neck*

0.796

(0.680–0.911)

0.760

(0.685–0.875)

0.877

(0.692–0.987)

 

Left total hip*

0.759

(0.615–0.869)

0.736

(0.610–0.867)

0.800

(0.655–0.921)

 

Left femoral neck*

0.797

(0.667–0.924)

0.764

(0.658–0.875)

0.853

(0.675–0.946)

Right distal femoral epiphysis**

0.888

(0.708–1.073)

0.853

(0.726–1.102)

0.874

(0.756–1.201)

Right distal femoral metaphysis**

0.744

(0.618–0.923)

0.785

(0.648–0.899)

0.934

(0.720–1.082)

Right proximal tibial epiphysis**

0.649

(0.508–0.772)

0.607

(0.545–0.775)

0.726

(0.572–0.872)

Left distal femoral epiphysis**

0.867

(0.693–1.047)

0.867

(0.744–1.116)

0.996

(0.803–1.140)

Left distal femoral metaphysis**

0.782

(0.634–0.916)

0.760

(0.672–0.874)

0.866

(0.722–1.060)

Left proximal tibial epiphysis**

0.642

(0.524–0.748)

0.615

(0.533–0.730)

0.665

(0.533–0.841)

 

Spine*

1.165

(1.037–1.364)

1.087

(0.943–1.202)

1.161

(0.931–1.332)

 

Radius*

0.918

(0.822–0.994)

0.780

(0.666–0.887)

0.790

(0.636–0.882)

Note. – ROI: region of interest; BMD: bone mineral density; SCI: spinal cord injury; IQR: interquartile range. *NHANES/Lunar data. **Toronto Rehab Protocol.

The median T score was also lower in the nontraumatic SCI group, as presented in Supplementary Material S Table 

S Table 1: Medians and interquartile ranges (IQRs) of T scores of the different spinal cord injury (SCI) groups.

ROI/T score

SCI Trauma Median (IQR)

SCI No Trauma Median (IQR)

SCI + Brain Injury Median (IQR)

Right total hip*

-2.0

(-3.0; -1.1)

-2.2

(-2.9; -1.2)

-1.6

(-2.7; -0.6)

Right femoral neck*

-1.7

(-2.5; -0.9)

-2.0

(-2.5; -1.2)

-1.1

(-2.3; -0.3)

Left total hip*

-1.9

(-3.0; -1.1)

-2.2

(-3.2; -1.1)

-1.7

(-2.6; -0.9)

Left femoral neck*

-1.7

(-2.5; -0.8)

-2.0

(-2.7; -1.2)

-1.3

(-2.4; -0.6)

Right distal femoral epiphysis**

-1.5

(-2.8; -0.1)

-1.6

(-2.7; 0.4)

-1.6

(-2.3; 0.8)

Right distal femoral metaphysis**

-2.3

(-3.5; -1.3)

-2.2

(-3.3; -1.3)

-1.2

(-2.7; 0.2)

Right proximal tibial epiphysis**

-1.7

(-2.5; -1.0)

-2.0

(-2.3; -1.0)

-1.3

(-2.2; -0.4)

Left distal femoral epiphysis**

-1.7

(-3.0; -0.4)

-1.5

(-2.4; 0.3)

-0.8

(-2.0; 0.6)

Left distal femoral metaphysis**

-2.3

(-3.4; -1.3)

-2.4

(-3.1; -1.4)

-1.5

(-2.6; -0.3)

Left proximal tibial epiphysis**

-1.8

(-2.4; -1.1)

-1.9

(-2.4; -1.3)

-1.6

(-2.4; -0.6)

Spine*

-0.1

(-1.2; 1.6)

-0.7

(-1.6; 0.2)

-0.2

(-2.12; 1.3)

Radius*

0.5

(-0.6; 1.3)

-0.9

(-1.5; 0.5)

-1.0

(-2.7; 0.1)

Note. – ROI: region of interest; SCI: spinal cord injury; IQR: interquartile range.

*NHANES/Lunar data. **Toronto Rehab Protocol.

1. After age correction, the traumatic SCI group had lower Z scores at the hip and knee sites, but in the spine and forearm, the median Z score was lower in the nontraumatic SCI group. These data can be verified in Supplementary Material S Table 2.

S Table 2: Medians and interquartile ranges (IQRs) of Z scores of the different spinal cord injury (SCI) groups.

ROI/Z score

SCI Trauma Median (IQR)

SCI No Trauma Median (IQR)

SCI + Brain Injury Median (IQR)

Right total hip*

-2.2

(-3.0; -1.3)

-1.7

(-2.4; -0.6)

-1.6

(-2.5; -0.7)

Right femoral neck*

-1.6

(-2.4; -0.7)

-1.2

(-1.9; -0.4)

-0.7

(-1.5; -0.1)

Left total hip*

-2.1

(-3.0; -1.2)

-1.5

(-2.7; -0.7)

-1.4

(-2.3; -0.5)

Left femoral neck*

-1.6

(-2.5; -0.7)

-1.2

(-2.0; -0.4)

-0.9

(-1.7; -0.1)

Right distal femoral epiphysis**

-1.8

(-3.2; -0.5)

-1.7

(-2.8; 0.1)

-1.7

(-2.4; 0.6)

Right distal femoral metaphysis**

-2.5

(-3.8; -1.5)

-2.4

(-3.4; -1.5)

-1.1

(-2.7; 0.1)

Right proximal tibial epiphysis**

-1.7

(-2.4; -0.9)

-1.4

(-2.1; -0.9)

-1.1

(-1.9; -0.3)

Left distal femoral epiphysis**

-1.9

(-3.2; -0.6)

-1.6

(-2.6; 0.1)

-0.7

(-2.1; 0.5)

Left distal femoral metaphysis**

-2.6

(-3.7; -1.6)

-2.4

(-3.2; -1.6)

-1.7

(-2.9; -0.5)

Left proximal tibial epiphysis**

-1.7

(-2.4; -1.1)

-1.5

(-2.0; -1.0)

-1.5

(-1.9; 0.2)

Spine*

-0.2

(-1.2; 1.5)

-0.6

(-1.5; 0.8)

-0.3

(-0.5; 1.7)

Radius*

-0.2

(-1.0; 0.5)

-0.7

(-1.8; 0.1)

-0.5

(-1.6; -0.1)

Note. – ROI: region of interest; SCI: spinal cord injury; IQR: interquartile range.

*NHANES/Lunar data. **Toronto Rehab Protocol.

The RMS at the distal metaphysis of the femur was 0.069 g/cm2, with a coefficient of variation (CV) of 1.90% and an SD of 0.025 g/cm2. At the distal epiphysis of the femur, the RMS was 0.053 g/cm2, with an RMS-CV of 2.90% and an RMS-SD of 0.019 g/cm2. Finally, at the proximal epiphysis of the tibia, the RMS was 0.038 g/cm2, with an RMS-CV of 1.82% and an RMS-SD of 0.014 g/cm2.

DISCUSSION

The main finding of this study is the high prevalence of osteoporosis and fragility fractures in SCI participants [1-17]. These results are consistent with previous studies and provide additional information by stratifying the risk within SCI individuals and comparing the different groups of participants with SCI. Osteoporosis was observed in approximately one-fourth of our sample, which is lower than the findings of another study. [5] In that study, osteopenia or osteoporosis was identified in over 80% of SCI individuals. Osteoporosis had a higher prevalence among nontraumatic SCI patients, affecting almost half of the participants. The frequency of osteoporosis in the nontraumatic SCI group was more than twice as high as that observed in the traumatic SCI group. Fragility fractures occurred in more than one in ten participants, with a higher rate observed in the nontraumatic SCI group, affecting over one-fifth of participants. When comparing the rate of fragility fractures between the nontraumatic and traumatic SCI groups, the rate was almost twice as high. The frequency of fragility fractures was similar to that in a previous study17. However, compared to other studies, [3,15,23] the rate was lower, ranging from as high as 50%, [3] 25-46%15 and 46-49%. [23] We believe that the criteria used to diagnose fragility fractures, excluding traumatic fractures, may account for the lower frequency.

The chance of fragility fractures is nearly four times higher in SCI participants with osteoporosis than in those with normal BMD. These findings align with previous studies reporting [5-23] times 4 and [4.3] times 5 higher chance in SCI participants. Physicians providing care to patients with SCI should maintain a high index of suspicion for fragility fractures, as they occur frequently [5-8,11,14 16,21,23,25-28] and patients may not manifest pain. Therefore, clinicians should remain vigilant for fragility fracture signs such as edema, fever, increased spasticity, and autonomic dysreflexia [2,16].

Therefore, our findings have implications for the SCI patient management. Osteoporosis and fragility fractures are clinical concerns in this population, leading to heightened morbidity, prolonged hospitalization, and increased treatment expenses. Therefore, routine screening for changes in BMD should be implemented in SCI patients, aligning with current ISCD recommendations [6,29] and the collective evidence from various studies [6,8-10,16-18,20,22,28,29].

SCI participants exhibit lower BMD, particularly in the distal femur and proximal tibia [1,4,6,8,11,12,15,16,18-24] thereby amplifying the chance of fragility fractures [5 8,11,14-16,21,23,25-28], as underscored by multiple cited authors. Conversely, BMD measurements of the spine and forearm in SCI patients hold lesser significance since they lie above the level of neurological injury [8,10,17,18,20,30,34], as elucidated by these investigations.

SCI participants had lower BMD, especially in the distal femur and proximal tibia [1,4,6,8,11,12,15,16,18 24], increasing the risk of fragility fractures [5-8,11,14 16,21,23,25-28], as previously mentioned by numerous cited authors. The BMD measurement of the spine and forearm in SCI may be less significant, particularly in individuals with paraplegia, as these areas are located above the neurological injury level [8,10,17,18,29,34,35], as indicated by these studies. However, it is important to consider that in tetraplegic patients may still experience low BMD measurements in the spine and forearm.

As stated in our previous study [17], participants exhibited higher values of RMS, RMS-CV, and RMS-SD at the distal femur compared to the proximal tibia. Precision studies should be conducted at least once, although they do not require regular repetition. These studies aid in understanding changes of lesser magnitude that cannot be determined with a statistically significant level of confidence, and thus they assist in the interpretation of longitudinal studies [31]. Our findings regarding the knee ROI demonstrated comparable values at the distal femur and proximal tibia, in line with other authors’ findings [20,32,33]. The observed larger difference at the distal femur may be attributed to the position of the patella.

This study has limitations, including its cross sectional and retrospective design conducted at a single rehabilitation center. Therefore, the generalizability of the results to other populations or centers may be limited. However, to mitigate selection bias, all patients who underwent the examination were included. The DXA scans were performed by a radiologist with over 25 years of experience who followed the ISCD methodology. The potential risk factors for osteoporosis and fragility fractures in SCI patients, such as the duration or level of injury, were not assessed, but the focus of this study was on the type of SCI rather than the time of injury, as extensive research has already been conducted regarding the latter. The impact of interventions such as pharmacological treatment or rehabilitation on BMD and fracture risk in SCI patients was not evaluated, as it was not the primary objective of this study, which was not designed as a prospective longitudinal multicenter study.

CONCLUSION

In conclusion, our study highlights the high prevalence of osteoporosis and fragility fractures in SCI participants, particularly in those with nontraumatic SCI. Routine screening for osteoporosis and fragility fractures, along with the implementation of prevention strategies, should be considered in the management of these patients.

Clinical Trial Registration

http://conselho.saude.gov.br/plataforma-brasil conep?view=default: CAAE 53530021.8.0000.0022, 28/12/2021

Summary Statement

After spinal cord injury, there are specific bone mineral changes that need to be properly evaluated by dual-energy absorptiometry (DXA), and there is also a greater chance of fragility fractures.

Key Results

• The chance of fragility fractures is nearly four times higher in patients with spinal cord injury and osteoporosis then in those with spinal cord injury and normal bone mineral density (p=0.005).

• Osteoporosis was identified in 81/358 (22.6%) spinal cord injury participants, and fragility fractures were observed in 46/358 (12.9%) spinal cord injury participants.

• Osteoporosis (28/68, 41.2%) and fragility fractures (14/68, 20.6%) were more frequent in the patients with nontraumatic spinal cord injury.

ACKNOWLEDGMENTS

I would like to thank the Rede SARAH who made this study possible.

REFERENCES

1. Uebelhart D, Demiaux-Domenech B, Roth M, Chantraine A. Bone metabolism in spinal cord injured individuals and in others who have prolonged immobilisation. A review. Paraplegia. 1995; 33: 669-73.

2. Bauman WA, Spungen AM. Metabolic changes in persons after spinal cord injury. Phys Med Rehabil Clin N Am. 2000; 11: 109-40.

3. Battaglino RA, Lazzari AA, Garshick E, Morse LR. Spinal cord injury induced osteoporosis: pathogenesis and emerging therapies. Curr Osteoporos Rep. 2012; 10: 278-85.

4. Troy KL, Morse LR. Measurement of Bone: Diagnosis of SCI-Induced Osteoporosis and Fracture Risk Prediction. Top Spinal Cord Inj Rehabil. 2015; 21: 267-274.

5. Abderhalden L, Weaver FM, Bethel M, Demirtas H, Burns S, Svircev J, et al. Dual-energy X-ray absorptiometry and fracture prediction in patients with spinal cord injuries and disorders. Osteoporos Int. 2017; 28: 925-934.

6. Morse LR, Biering-Soerensen F, Carbone LD, Cervinka T, Cirnigliaro CM, Johnston TE, et al. Bone Mineral Density Testing in Spinal Cord Injury: 2019 ISCD Official Position. J Clin Densitom. 2019; 22: 554 566.

7. Abdelrahman S, Ireland A, Winter EM, Purcell M, Coupaud S. Osteoporosis after spinal cord injury: aetiology, effects and therapeutic approaches. J Musculoskelet Neuronal Interact. 2021; 21: 26-50.

8. Ghatas MP, Sutor TW, Gorgey AS. Prediction of Distal Femur and Proximal Tibia Bone Mineral Density From Total Body Dual Energy X-Ray Absorptiometry Scans in Persons with Spinal Cord Injury. J Clin Densitom. 2022; 25: 252-260.

9. Sardar ZM, Coury JR, Cerpa M, DeWald CJ, Ames CP, Shuhart C, et al. Best Practice Guidelines for Assessment and Management of Osteoporosis in Adult Patients Undergoing Elective Spinal Reconstruction. Spine. 2022; 47: 128-135.

10. Shields RK, Schlechte J, Dudley-Javoroski S, Zwart BD, Clark SD, Grant SA, et al. Bone mineral density after spinal cord injury: a reliable method for knee measurement. Arch Phys Med Rehabil. 2005; 86: 1969-73.

11. Garland D, Adkins R, Stewart C. Fracture threshold and risk for osteoporosis and pathologic fractures in individuals with spinal cord injury. Top Spinal Cord Inj Rehabil. 2005; 11: 61-69.

12. Craven B, Blencowe L, McGillivray C, Adachi J. Detection and treatment of sublesional osteoporosis among patients with chronic spinal cord injury: proposed paradigms. Top Spinal Cord Inj Rehabil. 2009; 14: 1-22.

13. Carbone LD, Chin AS, Burns SP, Svircev JN, Hoenig H, Heggeness M, et al. Morbidity following lower extremity fractures in men with spinal cord injury. Osteoporos Int. 2013; 24: 2261-2267.

14. Carbone LD, Chin AS, Burns SP, Svircev JN, Hoenig H, Heggeness M, et al. Mortality after lower extremity fractures in men with spinal cord injury. J Bone Miner Res. 2014; 29: 432-439.

15. Champs APS, Maia GAG, Oliveira FG, de Melo GCN, Soares MMS. Osteoporosis-related fractures after spinal cord injury: a retrospective study from Brazil. Spinal Cord. 2020; 58: 484-489.

16. Sadowsky CL, Mingioni N, Zinski J. A Primary Care Provider’s Guide to Bone Health in Spinal Cord-Related Paralysis. Top Spinal Cord Inj Rehabil. 2020; 26: 128-133.

17. Cunha Jr AL, Precioso DR, Cotta AC, Champs APS. Cross-Sectional Study of Knee Bone Mineral Density and Fragility Fractures in Patients with Neurological Injuries and Neuromuscular Disorders. J Clin Densitom. 2022; 25: 682-691.

18. Gaspar AP, Lazaretti-Castro M, Brandão CM. Bone mineral density in spinal cord injury: an evaluation of the distal femur. J Osteoporos. 2012; 2012: 519754.

19. Imamura M, Takami MDP, Barbosa SBB, Silva AR, Pinheiro CM, Guerra LMC. et al. Osteoporosis in spinal cord injury: rehabilitation. Acta Fisiatr. 2013; 20: 112-117.

20. Peppler WT, Kim WJ, Ethans K, Cowley KC. Precision of dual-energy X-ray absorptiometry of the knee and heel: methodology and implications for research to reduce bone mineral loss after spinal cord injury. Spinal Cord. 2017; 55: 483-488.

21. Haider IT, Lobos SM, Simonian N, Schnitzer TJ, Edwards WB. Bone fragility after spinal cord injury: reductions in stiffness and bone mineral at the distal femur and proximal tibia as a function of time. Osteoporos Int. 2018; 29: 2703-2715.

22. Lobos S, Cooke A, Simonett G, Ho C, Boyd SK, Edwards WB. Trabecular Bone Score at the Distal Femur and Proximal Tibia in Individuals with Spinal Cord Injury. J Clin Densitom. 2019; 22: 249-256.

23. Frotzler A, Krebs J, Göhring A, Hartmann K, Tesini S, Lippuner K. Osteoporosis in the lower extremities in chronic spinal cord injury. Spinal Cord. 2020; 58: 441-448.

24. Weaver FM, Gonzalez B, Ray C, Etingen B, Schwartz A, Burns S, et al. Factors influencing providers’ decisions on management of bone health in people with spinal cord injury. Spinal Cord. 2021; 59: 787 795.

25. Akhigbe T, Chin AS, Svircev JN, Hoenig H, Burns SP, Weaver FM, et al. A retrospective review of lower extremity fracture care in patients with spinal cord injury. J Spinal Cord Med. 2015; 38: 2-9.

26. Bethel M, Bailey L, Weaver F, Harmon RL, Priebe MM, Le B, et al. A historical study of appendicular fractures in veterans with traumatic chronic spinal cord injury: 2002-2007. J Spinal Cord Med. 2016; 39: 686-692.

27. Zleik N, Weaver F, Harmon RL, Le B, Radhakrishnan R, Jirau Rosaly WD, et al. Prevention and management of osteoporosis and osteoporotic fractures in persons with a spinal cord injury or disorder: A systematic scoping review. J Spinal Cord Med. 2019; 42: 735-759.

28. Cirnigliaro CM, Parrott JS, Myslinski MJ, Asselin P, Lombard AT, La Fountaine MF, et al. Relationships between T-scores at the hip and bone mineral density at the distal femur and proximal tibia in persons with spinal cord injury. J Spinal Cord Med. 2020; 43: 685-695.

29. International Society for Clinical Densitometry. The ISCD’s official positions (updated 2019). Washington, DC: ISCD,2019.

30. Bauman WA, Schwartz E, Song IS, Kirshblum S, Cirnigliaro C, Morrison N, et al. Dual-energy X-ray absorptiometry overestimates bone mineral density of the lumbar spine in persons with spinal cord injury. Spinal Cord. 2009; 47: 628-633.

31. Bonnick SL, Johnston CC Jr, Kleerekoper M, Lindsay R, Miller P, Sherwood L, et al. Importance of precision in bone density measurements. J Clin Densitom. 2001; 4: 105-110.

32. McPherson JG, Edwards WB, Prasad A, Troy KL, Griffith JW, Schnitzer TJ. Dual energy X-ray absorptiometry of the knee in spinal cord injury: methodology and correlation with quantitative computed tomography. Spinal Cord. 2014; 52: 821-825.

33. Lobos S, Cooke A, Simonett G, Ho C, Boyd SK, Edwards WB. Assessment of Bone Mineral Density at the Distal Femur and the Proximal Tibia by Dual-Energy X-ray Absorptiometry in Individuals with Spinal Cord Injury: Precision of Protocol and Relation to Injury Duration. J Clin Densitom. 2018; 21: 338-346.

34. Kannisto M, Alaranta H, Merikanto J, Kröger H, Kärkkäinen J. Bone mineral status after pediatric spinal cord injury. Spinal Cord. 1998; 36: 641-646.

35. ASIA and ISCoS International Standards Committee. The 2019 revision of the International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI)-What’s new? Spinal Cord. 2019; 57: 815-817.

Cunha A, Jr (2025) Densitometric Evaluation and Fragility Fractures after Spinal Cord Injury. J Neurol Disord Stroke 12(1): 1231.

Received : 17 Nov 2024
Accepted : 27 Feb 2025
Published : 03 Mar 2025
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X